A Study of Nivolumab by Itself or Nivolumab Combined With Ipilimumab in Patients With Advanced or Metastatic Solid Tumors
Clinical trial NCT01928394 · COMPLETED
Trial details
- NCT number
- NCT01928394
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-24
- Primary completion
- 2019-02-05
- Enrollment
- 1163
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.